About CRA | Expertise | Consultants | Publications | News | Events | Offices | Careers                                                                         
Take a closer look. The European Commission launched a sector inquiry into the pharmaceutical
industry, targeting allegations that generic entry was delayed and innovation had declined. On behalf
of EFPIA, the branded manufacturers' trade association, CRA responded with two reports discussing
competition and innovation in pharmaceutical markets.


CRA’s Brussels office primarily provides competition policy advice for cases in front of the European Commission and economic and financial consulting services for cases in front of domestic competition authorities in Europe. Since opening in 2001, the office has played an important role in matters covering the full range of competition policy, including mergers, Article 81 and 82 cases, state aid and intellectual property issues. We also provide global antitrust and merger coverage, litigation support on commercial damages cases and regulatory analysis.

81 Avenue Louise
B-1050 Brussels
+32-2-627-1400 Tel
+44-20-7664-3998 Fax

Regional expertise

Global expertise


Raphaël  De Coninck
Vice President and Legal Representative of the Brussels Office

Hans Zenger
Senior Consultant to CRA